Researchers have been excited about this new drug, a groundbreaking dual agonist showing remarkable results in clinical trials for size reduction . It works by targeting several systems: GLP-1 and GIP, that , when activated , support regulate hunger and boost calorie burn. Initial observations suggest considerable body loss and likely advantages… Read More